Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
ABIONYX Pharma SA (GB:0RAG)
LSE:0RAG
ABIONYX Pharma SA (0RAG) Share Price & Analysis
0 Followers
0RAG Stock Chart & Stats
Day’s Range€1.09 - €1.09
52-Week Range― - ―
Previous Close€1.09
Volume0.00
Average Volume (3M)N/A
Market Cap
€32.95M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
Sep 26, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. Volume0
Standard Deviation0.28
R-Squared0.02
Alpha-0.09
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
0RAG FAQ
What was ABIONYX Pharma SA’s price range in the past 12 months?
Currently, no data Available
What is ABIONYX Pharma SA’s market cap?
Currently, no data Available
When is ABIONYX Pharma SA’s upcoming earnings report date?
ABIONYX Pharma SA’s upcoming earnings report date is Sep 26, 2024 which is in 150 days.
How were ABIONYX Pharma SA’s earnings last quarter?
ABIONYX Pharma SA released its earnings results on Mar 11, 2024. The company reported -€0.039 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.039.
Is ABIONYX Pharma SA overvalued?
According to Wall Street analysts ABIONYX Pharma SA’s price is currently Overvalued.
Does ABIONYX Pharma SA pay dividends?
ABIONYX Pharma SA does not currently pay dividends.
What is ABIONYX Pharma SA’s EPS estimate?
ABIONYX Pharma SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ABIONYX Pharma SA have?
Currently, no data Available
What happened to ABIONYX Pharma SA’s price movement after its last earnings report?
ABIONYX Pharma SA reported an EPS of -€0.039 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.587%.
Which hedge fund is a major shareholder of ABIONYX Pharma SA?
Currently, no hedge funds are holding shares in GB:0RAG
---
ABIONYX Pharma SA Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Company Description
ABIONYX Pharma SA
ABIONYX Pharma SA is a biopharmaceutical company, which engages in discovery and development of novel therapies based on high-density lipoproteins and the metabolism of lipids for the treatment of associated cardiovascular and metabolic diseases. Its therapies consist of CER 001 and 209. The company was founded by Jean-Louis Dasseux and William F. Brinkerhoff on March 24, 2005 and is headquartered in Labege, France.
---
Technical Analysis
---